Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Neurizon Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
PharmAust says its cancer drug for fussy dogs is way tastier now
Health & Biotech
PharmAust’s anti-cancer drug passed an important test on the way to human trials
Health & Biotech
PharmAust wins all-important licence to start testing its doggy cancer pill
Health & Biotech
PharmAust pinches key exec from animal health company Elanco
Health & Biotech
